Startseite Congenital hypothyroidism and thyroid dyshormonogenesis: a case report of siblings with a newly identified mutation in thyroperoxidase
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Congenital hypothyroidism and thyroid dyshormonogenesis: a case report of siblings with a newly identified mutation in thyroperoxidase

  • David P. Sparling ORCID logo , Kendra Fabian , Lara Harik , Vaidehi Jobanputra , Kwame Anyane-Yeboa , Sharon E. Oberfield und Ilene Fennoy EMAIL logo
Veröffentlicht/Copyright: 19. Februar 2016

Abstract

Background: Thyroid dyshormonogenesis continues to be a significant cause of congenital hypothyroidism. Over time, forms of thyroid dyshormonogenesis can result in goiter, which can lead to difficult management decisions as the pathologic changes can both mimic or lead to thyroid cancer.

Methods: Herein we describe the cases of two brothers diagnosed with congenital hypothyroidism, with initial findings consistent with thyroid dyshormonogenesis. One brother eventually developed multinodular goiter with complex pathology on biopsy, resulting in thyroidectomy.

Results: Whole exome sequencing revealed the brothers carry a novel frameshift mutation in thyroperoxidase; the mutation, while not previously described, was likely both deleterious and pathogenic.

Conlcusions: These cases highlight the complex pathology that can occur within thyroid dyshormonogenesis, with similar appearance to possible thyroid cancer, leading to complex management decisions. They also highlight the role that a genetic diagnosis can play in interpreting the impact of dyshormonogenesis on nodular thyroid development, and the need for long-term follow-up in these patients.


Corresponding author: Ilene Fennoy, MD, MPH, Division of Pediatric Endocrinology, Diabetes, and Metabolism, Department of Pediatrics, Columbia University Medical Center, 622 West 168th St, PH-5E-522, New York, NY 10032, USA, Phone: +212-305-6559; Fax: +212-305-4778, E-mail:

Acknowledgments

The authors would like to thank Dr. Ronald Ghossein at Memorial Sloan Kettering Cancer Center in New York, NY, USA and Dr. Juan Rosai at Centro Diagnostico Italiano in Milan, Italy for their aid in this case.

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: DPS was supported by a NIH/NIDDK grant to SEO (T32-DK065522).

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Kratzsch J, Pulzer F. Thyroid gland development and defects. Best Pract Res Clin Endocrinol Metab 2008;22:57–75.10.1016/j.beem.2007.08.006Suche in Google Scholar PubMed

2. Castanet M, Polak M, Bonaiti-Pellie C, Lyonnet S, Czernichow P, et al. Nineteen years of national screening for congenital hypothyroidism: familial cases with thyroid dysgenesis suggest the involvement of genetic factors. J Clin Endocrinol Metab 2001;86:2009–14.10.1210/jcem.86.5.7501Suche in Google Scholar PubMed

3. Leger J, Marinovic D, Garel C, Bonaiti-Pellie C, Polak M, et al. Thyroid developmental anomalies in first degree relatives of children with congenital hypothyroidism. J Clin Endocrinol Metab 2002;87:575–80.10.1210/jcem.87.2.8268Suche in Google Scholar PubMed

4. Szinnai G. Genetics of normal and abnormal thyroid development in humans. Best Pract Res Clin Endocrinol Metab 2014;28:133–50.10.1016/j.beem.2013.08.005Suche in Google Scholar PubMed

5. Moreno JC, Klootwijk W, van Toor H, Pinto G, D’Alessandro M, et al. Mutations in the iodotyrosine deiodinase gene and hypothyroidism. N Eng J Med 2008;358:1811–8.10.1056/NEJMoa0706819Suche in Google Scholar PubMed

6. Pardo V, Rubio IG, Knobel M, Aguiar-Oliveira MH, Santos MM, et al. Phenotypic variation among four family members with congenital hypothyroidism caused by two distinct thyroglobulin gene mutations. Thyroid 2008;18:783–6.10.1089/thy.2007.0321Suche in Google Scholar PubMed

7. Pohlenz J, Rosenthal IM, Weiss RE, Jhiang SM, Burant C, et al. Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3’ splice site. J Clin Invest 1998;101:1028–35.10.1172/JCI1504Suche in Google Scholar PubMed PubMed Central

8. Spitzweg C, Morris JC. Genetics and phenomics of hypothyroidism and goiter due to NIS mutations. Mol Cell Endocrinol 2010;322:56–63.10.1016/j.mce.2010.02.007Suche in Google Scholar PubMed PubMed Central

9. Zamproni I, Grasberger H, Cortinovis F, Vigone MC, Chiumello G, et al. Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a novel cause of congenital hypothyroidism. J Clin Endocrinol Metab 2008;93:605–10.10.1210/jc.2007-2020Suche in Google Scholar PubMed PubMed Central

10. Grasberger H, Refetoff S. Genetic causes of congenital hypothyroidism due to dyshormonogenesis. Curr Opin Pediatr 2011;23:421–8.10.1097/MOP.0b013e32834726a4Suche in Google Scholar PubMed PubMed Central

11. Ris-Stalpers C, Bikker H. Genetics and phenomics of hypothyroidism and goiter due to TPO mutations. Mol Cell Endocrinol 2010;322:38–43.10.1016/j.mce.2010.02.008Suche in Google Scholar PubMed

12. Ghossein RA, Rosai J, Heffess C. Dyshormonogenetic goiter: a clinicopathologic study of 56 cases. Endocr Pathol 1997;8:283–92.10.1007/BF02739930Suche in Google Scholar PubMed

13. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009;4:1073–81.10.1038/nprot.2009.86Suche in Google Scholar PubMed

14. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248–9.10.1038/nmeth0410-248Suche in Google Scholar PubMed PubMed Central

15. Richards S, Aziz N, Bale S, Bick D, Das S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405–24.10.1038/gim.2015.30Suche in Google Scholar PubMed PubMed Central

16. Grosse SD, Van Vliet G. Prevention of intellectual disability through screening for congenital hypothyroidism: how much and at what level? Arch Dis Child 2011;96:374–9.10.1136/adc.2010.190280Suche in Google Scholar PubMed

17. Cameo T, Gumer LB, Williams KM, Gomez J, McMahon DJ, Oberfield SE. A retrospective review of newborn screening for congenital hypothyroidism and newborn thyroid disease at a major medical center. Clin Pediatr 2013;52:1054–8.10.1177/0009922813491824Suche in Google Scholar PubMed PubMed Central

18. Donaldson M, Jones J. Optimising outcome in congenital hypothyroidism; current opinions on best practice in initial assessment and subsequent management. J Clin Res Pediatr Endocrinol 2013;5(Suppl 1):13–22.10.4274/jcrpe.849Suche in Google Scholar PubMed PubMed Central

19. Ruf J, Carayon P. Structural and functional aspects of thyroid peroxidase. Arch Biochem Biophys 2006;445: 269–77.10.1016/j.abb.2005.06.023Suche in Google Scholar PubMed

20. Kimura S, Hong YS, Kotani T, Ohtaki S, Kikkawa F. Structure of the human thyroid peroxidase gene: comparison and relationship to the human myeloperoxidase gene. Biochemistry 1989;28:4481–9.10.1021/bi00436a054Suche in Google Scholar PubMed

21. Avbelj M, Tahirovic H, Debeljak M, Kusekova M, Toromanovic A, et al. High prevalence of thyroid peroxidase gene mutations in patients with thyroid dyshormonogenesis. Eur J Endocrinol 2007;156:511–9.10.1530/EJE-07-0037Suche in Google Scholar PubMed

22. Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med 2013;369:1502–11.10.1056/NEJMoa1306555Suche in Google Scholar PubMed PubMed Central

23. Nguyen MT, Charlebois K. The clinical utility of whole-exome sequencing in the context of rare diseases – the changing tides of medical practice. Clin Genet 2015;88:313–9.10.1111/cge.12546Suche in Google Scholar PubMed

24. Corrias A, Mussa A. Thyroid nodules in pediatrics: which ones can be left alone, which ones must be investigated, when and how. J Clin Res Pediatr Endocrinol 2013;5(Suppl 1):57–69.10.4274/jcrpe.853Suche in Google Scholar PubMed PubMed Central

25. Chertok Shacham E, Ishay A, Irit E, Pohlenz J, Tenenbaum-Rakover Y. Minimally invasive follicular thyroid carcinoma developed in dyshormonogenetic multinodular goiter due to thyroid peroxidase gene mutation. Thyroid 2012;22:542–6.10.1089/thy.2011.0478Suche in Google Scholar PubMed

26. Raef H, Al-Rijjal R, Al-Shehri S, Zou M, Al-Mana H, et al. Biallelic p.R2223H mutation in the thyroglobulin gene causes thyroglobulin retention and severe hypothyroidism with subsequent development of thyroid carcinoma. J Clin Endocrinol Metab 2010;95:1000–6.10.1210/jc.2009-1823Suche in Google Scholar PubMed

27. Francis G, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer the american thyroid association guidelines task force on pediatric thyroid cancer. Thyroid 2015;25:716–59.10.1089/thy.2014.0460Suche in Google Scholar PubMed PubMed Central

Received: 2015-6-23
Accepted: 2015-12-14
Published Online: 2016-2-19
Published in Print: 2016-5-1

©2016 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Review
  3. Resistance to thyroid hormone α, revelation of basic study to clinical consequences
  4. Original Articles
  5. Improved molecular diagnosis of patients with neonatal diabetes using a combined next-generation sequencing and MS-MLPA approach
  6. Safety and metabolic impact of Ramadan fasting in children and adolescents with type 1 diabetes
  7. Waist-to-height ratio as a marker of low-grade inflammation in obese children and adolescents
  8. Classification and clinical characterization of metabolically “healthy” obese children and adolescents
  9. Long-term BH4 (sapropterin) treatment of children with hyperphenylalaninemia – effect on median Phe/Tyr ratios
  10. Compound heterozygous mutations (p.T561M and c.2422delT) in the TPO gene associated with congenital hypothyroidism
  11. Prevalence and clinical features of polycystic ovarian syndrome in adolescents with previous childhood growth hormone deficiency
  12. Urate crystals deposition in the feet of overweight juveniles and those with symptomatic hyperuricemia: a dual-energy CT study
  13. A novel ALMS1 homozygous mutation in two Turkish brothers with Alström syndrome
  14. Novel AVPR2 mutation causing partial nephrogenic diabetes insipidus in a Japanese family
  15. Pituitary gigantism: a retrospective case series
  16. Case Reports
  17. A novel OTX2 gene frameshift mutation in a child with microphthalmia, ectopic pituitary and growth hormone deficiency
  18. A novel nonsense mutation in the WFS1 gene causes the Wolfram syndrome
  19. A 33-year-old male patient with paternal derived duplication of 14q11.2–14q22.1~22.3: clinical course, phenotypic and genotypic findings
  20. Familial Turner syndrome: the importance of information
  21. De novo mutation of PHEX in a type 1 diabetes patient
  22. Congenital hypothyroidism and thyroid dyshormonogenesis: a case report of siblings with a newly identified mutation in thyroperoxidase
Heruntergeladen am 18.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2015-0253/html
Button zum nach oben scrollen